XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jul. 31, 2025
Jul. 31, 2024
Cash flows from operating activities    
Net loss $ (88,378) $ (135,911)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Allowance for expected credit losses 1,193 372
Depreciation and amortization 10,109 8,293
Amortization of deferred contract acquisition costs 13,769 12,493
Stock-based compensation expense 110,321 108,747
Net accretion of discount on marketable securities (1,278) (3,556)
Non-cash lease expense 9,122 8,888
Amortization of discount on revolving credit facility and term loan issuance costs 60 61
Changes in operating assets and liabilities:    
Accounts receivable 17,767 22,914
Prepaid expenses and other current assets (20,179) (13,598)
Other assets 274 (3,081)
Accounts payable 6,261 6,369
Accrued expenses and other liabilities (12,170) (6,373)
Deferred revenue 10,820 17,970
Operating lease liabilities (11,092) (9,628)
Net cash provided by operating activities 46,599 13,960
Cash flows from investing activities    
Purchases of marketable securities (104,096) (107,126)
Maturities of marketable securities 96,576 91,296
Purchases of property and equipment (1,935) (2,692)
Capitalized internal-use software costs (5,287) (2,783)
Net cash used in investing activities (14,742) (21,305)
Cash flows from financing activities    
Repayment of term loan (2,500) (1,250)
Repurchases of common stock (43,398) (19,022)
Proceeds from exercise of stock options 2,073 2,129
Proceeds from employee stock purchase plan 7,746 8,866
Taxes paid related to net share settlement of equity awards 0 (4)
Net cash used in financing activities (36,079) (9,281)
Effect of foreign exchange rates on cash, cash equivalents, and restricted cash 4,030 (182)
Net decrease in cash, cash equivalents, and restricted cash (192) (16,808)
Cash, cash equivalents, and restricted cash    
Beginning of period 184,864 236,663
End of period 184,672 219,855
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets    
Cash and cash equivalents 184,146 219,400
Restricted cash 526 455
Total cash, cash equivalents, and restricted cash 184,672 219,855
Supplemental cash flow data    
Cash paid for income taxes 1,259 2,587
Supplemental non-cash investing and financing information    
Purchase of property and equipment in accounts payable and accrued expenses and other current liabilities 182 447
Stock-based compensation expense capitalized for internal-use software 3,555 1,953
Repurchases of common stock in accrued expenses and other current liabilities $ 0 $ 698